Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- kinvardbio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Boston University | 75A50122C00028 | $452,265 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of oxepanoprolinamide antibiotics for the treatment of complicated urinary tract infections. | National Institute of Allergy and Infectious Diseases (NIH) | $314,363 |
Quick answers
Is Kinvard Bio, Inc. registered in SAM.gov?
Yes. Kinvard Bio, Inc.'s SAM.gov registration is active through November 6, 2027.
What is Kinvard Bio, Inc.'s most recent federal award?
Kinvard Bio, Inc.'s most recent federal grant award is Development of oxepanoprolinamide antibiotics for the treatment of complicated urinary tract infections (R43AI197431), from National Institute of Allergy and Infectious Diseases (NIH), on August 3, 2026.
On GovTribe
See Kinvard Bio, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors